Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
14 May 2025 | Story Tshepo Tsotetsi | Photo Tshepo Tsotetsi
Multilingualism stakeholder engagement session
Prof Vasu Reddy, UFS Deputy Vice-Chancellor: Research and Internationalisation; guest speaker Prof Leketi Makalela; and Dr Nomalungelo Ngubane, Director of the UFS Academy for Multilingualism.

Multilingualism is not just a concept at the University of the Free State (UFS) – it is a growing practice, a challenge, and an opportunity all at once. This was made clear during a stakeholder engagement session on 7 May 2025, hosted by the Academy for Multilingualism at the UFS’s Bloemfontein Campus, where staff, academics, and strategic partners gathered to reflect on the university’s language journey.

In his reflections, the Deputy Vice-Chancellor for Research and Internationalisation, Prof Vasu Reddy, emphasised that, “Scholarly conversations such as these are not just simply intellectually important, but socially and politically, and it is critical to learn from each other, exchange ideas, and make change.” He described the Academy as a “novel intervention” and noted how engagements like this help “break silos that languages sometimes create” – a crucial step towards realising the promise of multilingualism and translanguaging in academic spaces.

 

Progress, challenges, and collective ownership

In her presentation, Dr Nomalungelo Ngubane, Director of the Academy for Multilingualism, provided an overview of the institutional language policy and its implementation status, now in its third year of a five-year plan. She highlighted key strides: the translation of 116 PhD abstracts into Sesotho, Afrikaans, and isiXhosa; the development of South African Sign Language terminology in psychology; and the training of 16 tutors in translanguaging, among others.

Dr Ngubane stressed the importance of shared ownership of the policy’s rollout. “It’s very important that the language policy is understood by all stakeholders. It’s a collective journey, and it becomes even more powerful when people own it and take it forward into their departments, faculties, and student spaces,” she said. While she acknowledged that meaningful development of African languages as academic mediums is costly and resource-intensive, she noted that small, deliberate steps are being taken.

 

Ubuntu translanguaging: rethinking the classroom

The keynote address was delivered by Prof Leketi Makalela, full professor and founding Director of the Hub for Multilingual Education and Literacies at the University of the Witwatersrand. A globally recognised scholar and the holder of the SARChI Chair in Advancing African Languages for Social Inclusion and Access, Prof Makalela added a powerful perspective rooted in research and teaching practice.

He began his address with a reflection: “I believe I landed on this little rock called Earth to ensure that human beings have deep access to the world in which they were born, and you can only be part of this greater world and make full sense of it through language.”

Later, he challenged the monolingual mindsets that dominate higher education. “People still want to treat languages as different entities, and that’s where the issue is. That’s where the education system is not aligning with the realities of multilinguality.” 

Prof Makalela said multilingual students face dual disadvantages: compromised epistemic access [access to knowledge systems] due to monolingual bias, and diminished identity affirmation. His response? Ubuntu translanguaging – a model that embraces cohabitation of languages and student-led meaning-making.

“It’s a misconception that the lecturer must translanguage,” he said. “It is the student who should translanguage. The lecturer should only facilitate and respect that internal process.”

He outlined a clear, three-step translanguaging teaching method:

• Pre-lesson: Activate prior learning and scaffold vocabulary and concepts.
• During lesson: Create space for multilingual thinking – allow students to write, reflect, and engage in their own languages.

• Post-lesson: Validate understanding, and open the classroom to diverse linguistic expressions.

Prof Makalela stressed that the real innovation lies in normalising these practices institution-wide. “Existing multilingual tutorials are useful, but real transformation happens when every lecturer opens up their lessons to multilingual engagement.”

News Archive

Research contributes to improving quality of life for cancer patients
2016-11-21

Description: Inorganic Chemistry supervisors  Tags: Inorganic Chemistry supervisors

Inorganic Chemistry supervisors in the Radiopharmacy
Laboratory during the preparation of a typical complex
mixture to see how fast it reacts. Here are, from the left,
front: Dr Marietjie Schutte-Smith, Dr Alice Brink
(both scholars from the UFS Prestige
Scholar Programme), and Dr Truidie Venter (all three
are Thuthuka-funded researchers).
Back: Prof André Roodt and Dr Johan Venter.
Photo: Supplied

Imagine that you have been diagnosed with bone cancer and only have six months to live. You are in a wheelchair because the pain in your legs is so immense that you can’t walk anymore – similar to a mechanism eating your bones from the inside.

You are lucky though, since you could be injected with a drug to control the pain so effective that you will be able to get out of the wheelchair within a day-and-a-half and be able to walk again. Real-life incidents like these provide intense job satisfaction to Prof André Roodt, Head of Inorganic Chemistry at the University of the Free State (UFS). The research, which is conducted by the Inorganic Group at the UFS, contributes greatly to the availability of pain therapy that does not involve drugs, but improves the quality of life for cancer patients.

The research conducted by the Inorganic Group under the leadership of Prof Roodt, plays a major role in the clever design of model medicines to better detect and treat cancer.

The Department of Chemistry is one of approximately 10 institutions worldwide that conducts research on chemical mechanisms to identify and control cancer. “The fact that we are able to cooperate with the Departments of Nuclear Medicine and Medical Physics at the UFS, the Animal Research Centre, and other collaborators in South Africa and abroad, but especially the methodology we utilise to conduct research (studying the chemical manner in which drugs are absorbed in cancer as well as the time involved), enhances the possibility of making a contribution to cancer research,” says Prof Roodt.

Technique to detect cancer spots on bone
According to the professor, there are various ways of detecting cancer in the body. Cancer can, inter alia, be identified by analysing blood, X-rays (external) or through an internal technique where the patient is injected with a radioactive isotope.

Prof Roodt explains: “The doctor suspects that the patient has bone cancer and injects the person with a drug consisting of an isotope (only emits X-rays and does no damage to tissue) that is connected to a phosphonate (similar to those used for osteoporosis). Once the drug is injected, the isotope (Technetium-99m) moves to the spot on the bone where the cancer is located. The gamma rays in the isotope illuminate the area and the doctor can see exactly where treatment should be applied. The Technetium-99m has the same intensity gamma rays as normal X-rays and therefore operates the same as an internal X-ray supply.” With this technique, the doctor can see where the cancer spots are within a few hours.

The same technique can be used to identify inactive parts of the brain in Alzheimer patients, as well as areas of the heart where there is no blood supply or where the heart muscle is dead.

Therapeutic irradiation of cancer
For the treatment of pain connected with cancer, the isotope Rhenium-186 is injected. Similar to the manner in which the Technetium-99m phosphonate compound is ingested into the body, the Rhenium-186 phosphonate travels to the cancer spots. Patients thus receive therapeutic irradiation – a technique known as palliative therapy, which is excellent for treating pain. A dosage of this therapy usually lasts for about two months.

The therapy is, however, patient specific. The dosages should correspond with the occurrence and size of cancer spots in the patient’s body. First, the location of the cancer will be determined by means of a technetium scan. After that, the size of the area where the cancer occurs has to be determined. The dosage for addressing total pain distribution will be calculated according to these results.

Technique to detect cancer spots on soft tissue
Another technique to detect cancer as spots on bone or in soft tissue and organs throughout the body is by utilising a different type of irradiation, a so-called PET isotope. The Fluor-18 isotope is currently used widely, and in Pretoria a machine called a cyclotron was produced by Dr Gerdus Kemp, who is a former PhD graduate from the Inorganic Research Group. The F-18 is then hidden within a glucose molecule and a patient will be injected with the drug after being tranquillised and after the metabolism has been lowered considerably. The glucose, which is the ‘food' that cancer needs to grow, will then travel directly to the cancer area and the specific area where the cancer is located will thus be traced and ‘illuminated’ by the Fluor-18, which emits its own 'X-rays'.

In the late 80s, Prof Roodt did his own postdoctoral study on this research in the US. He started collaborating with the Department of Nuclear Medicine at the UFS in the early 90s, when he initiated testing for this research.

Through their research of more than 15 years, the Inorganic Group in the Department of Chemistry has made a major contribution to cancer research. Research on mechanisms for the detection of cancer, by designing new clever chemical agents, and the chemical ways in which these agents are taken up in the body, especially contributes to the development in terms of cancer therapy and imaging, and has been used by a number of hospitals in South Africa.

The future holds great promise
Prof Roodt and his team are already working on a bilateral study between the UFS and Kenya. It involves the linking of radio isotopes, as mentioned above, to known natural products (such as rooibos tea), which possess anti-cancer qualities.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept